Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

October 30, 2024

A Closer Look at the ACURATE IDE Study

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Benefits of MR Elimination & "Why TMVR"

Presentation TCT 2024

Benefits of MR Elimination & "Why TMVR"

Presenter: Michael Reardon

October 29, 2024

Global Experience With Transapical TMVR - Does Access Impact Clinical Outcomes?

Presentation NY Valves 2024

Global Experience With Transapical TMVR - Does Access Impact Clinical Outcomes?

Presenter: Michael J. Reardon

June 07, 2024

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Presentation NY Valves 2024

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Presenter: Michael J. Reardon

June 07, 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Hemodynamic Performance and Restoration of Laminar Flow

Presentation NY Valves 2024

Hemodynamic Performance and Restoration of Laminar Flow

Presenter: Michael J. Reardon

June 05, 2024

The Lifetime Management of Aortic Stenosis: A Heart Team Perspective

Presentation NY Valves 2024

The Lifetime Management of Aortic Stenosis: A Heart Team Perspective

Presenter: Michael J. Reardon

June 05, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.